Full Text View
Tabular View
No Study Results Posted
Related Studies
Measurement Skin Temperature During Pulsed Laser Exposure
This study is enrolling participants by invitation only.
Study NCT00540917   Information provided by University of California, Irvine
First Received: October 4, 2007   Last Updated: March 12, 2009   History of Changes

October 4, 2007
March 12, 2009
July 2002
July 2012   (final data collection date for primary outcome measure)
skin temperature during laser treatment [ Time Frame: 90 days ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00540917 on ClinicalTrials.gov Archive Site
 
 
 
Measurement Skin Temperature During Pulsed Laser Exposure
Phase II Clinical Trial is to Compare Epidermal Temperature Measurements During 1.Laser Treatment at Standard Treatment Energies 2.Cryogen Spray Cooling (CSC) Plus Laser Treatment. 3.Contact Cooling Plus Laser Treatment.

Lasers are the treatment modality of choice for Port Wine Stain birthmarks.The epidermis is not totally spared due to partial absorption of energy therein by melanin that presents an optical barrier through which the light must pass to reach the underlying blood vessels. Absorption of laser energy by melanin causes localized heating in the epidermis, which may, if not controlled, produce permanent complications such as hypertrophic scarring or dyspigmentation.

The researchers want to establish a correlation between non-invasive skin temperature measurements and the minimum laser energy during skin laser treatment using cryogen spray cooling.

This study would eliminate the need for test pulses to estimate the safe and acceptable radiant exposure prior to laser treatment.

Phase II
Interventional
Treatment, Open Label, Single Group Assignment, Safety/Efficacy Study
Port Wine Stain Birthmark
Procedure: cooling spray during laser treatment
Experimental: during laser treatment of portwine stain skin
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Enrolling by invitation
300
July 2012
July 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 7 years of age and older with diagnosis of port wine stain birthmark
  • 18 years of age and older with no port wine stain
  • non-pregnant women
  • apparent good health

Exclusion Criteria:

  • age less than 7 years old
  • pregnant women
  • history of photodermatoses or skin cancer
  • current use of photosensitizing drugs
Both
7 Years to 75 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00540917
John S. Nelson, M.D., Ph.D, Beckman Laser Institute
CANDELAR can-44711, ASLMS-41746, LAMMP RR-01192-29
University of California, Irvine
  • Beckman Laser Institute University of California Irvine
  • Candela Corporation
Principal Investigator: John S. Nelson, M.D., Ph.D Beckman Laser Institute University of California Irvine
University of California, Irvine
March 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP